AI can predict a woman’s survival rate and response to treatments for ovarian cancer more accurately than current methods, according to research published online Feb. 15 in Nature Communications. 

Medical device company Sight Diagnostics has raised $27.8 million in funding to expand its system that uses AI to analyze blood tests, according to a report by VentureBeat.

The new American Society of Breast Surgeons' recommendations are based on a comprehensive review of the most impactful evidence in modern literature, data and national guidelines.

It will take close collaboration between governmental bodies and private businesses to achieve interoperability across U.S. healthcare. There’s no big news in that. However, a high-powered panel fleshed out the details on the necessity Feb. 14 at HIMSS19 in Orlando.

Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons. 

The U.S. Food and Drug Administration approved the country’s first interoperable insulin pump Feb. 14, reporting the technology will help diabetics better individualize their treatment regimens.

Catch up on all things fraud and ethics around the healthcare industry with HealthExec’s weekly watchdog report.

IBM Watson Health is partnering with the Broad Institute of MIT and Harvard to use AI and genomics to help clinicians better predict the onset of serious cardiovascular diseases, the company announced Feb. 13.

Results from President Donald Trump’s latest physical, released Feb. 14., reveal the president’s overall cholesterol has improved since last year’s check-up, according to the Associated Press. But Trump has also gained weight and is now classified as obese, which could raise his already elevated risk for heart disease.

Researchers at West Virginia University (WVU) were awarded a $1 million grant from the National Institute of Justice to develop novel AI techniques to combat the opioid epidemic and opioid trafficking. The funding will be provided over a three-year period.